查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1636664

2030 年麩胺基硫市場預測：按產品類型、形式、來源、應用和地區進行的全球分析

Glutathione Market Forecasts to 2030 - Global Analysis By Product Type, Form, Source, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球麩胺基硫市場預計為 4.0293 億美元，預測期內複合年成長率為 10.2%，預計到 2030 年將達到 7.2164 億美元。

麩胺基硫是一種強大的抗氧化劑，天然存在於細胞內，由三種胺基酸組成：麩醯胺酸、半胱胺酸和甘胺酸。它透過清除損害細胞並導致老化和慢性疾病的自由基和活性氧，在保護身體免受氧化壓力發揮重要作用。麩胺基硫也是許多代謝功能所必需的，包括免疫系統功能、蛋白質修復和 DNA 合成。它還可以透過與毒素結合並將排放肝臟來幫助解毒危險物質。此外，麩胺基硫因其許多健康益處而被廣泛用於補充劑和護膚品中，特別是它能夠改善皮膚健康和促進膚色平衡。

根據《歐洲醫學與健康科學雜誌》報導，麩胺基硫（GSH）是人體中最豐富的內源性合成自由基清除劑，缺乏會對健康產生負面影響。研究表明，慢性病患者的麩胺基硫水平降低高達 50%。

增加有關健康益處的知識

推動市場擴張的主要因素之一是人們越來越認知到麩胺基硫的健康益處。麩胺基硫是一種強大的抗氧化劑，有助於減少氧化壓力併中和自由基，這兩者都與衰老和糖尿病、癌症和心血管疾病等慢性疾病有關。它受到注重健康的消費者的青睞，因為它能夠增強免疫系統並普遍改善細胞健康。此外，由於人們意識的增強，對麩胺基硫補充劑的需求也在增加，特別是對於那些希望改善整體健康狀況和避免慢性疾病的人。

昂貴的製造和產品成本

生產成本高是限制麩胺基硫市場的主要因素之一。合成麩胺基硫，特別是還原態和生物可利用形式的穀胱甘肽，需要先進的技術和大量的研發投資。因此，麩胺基硫產品和補充劑比其他抗氧化劑更昂貴，因為生產成本增加轉嫁給了客戶。此外，由於其成本較高，一些富裕且注重健康的消費者往往不會購買麩胺基硫，這限制了其開拓市場的能力，特別是在開發中國家和其他價格敏感的地區。

對預防性醫療解決方案的需求不斷成長

由於人們越來越重視預防保健，麩胺基硫市場前景廣闊。隨著人們對維持免疫和細胞健康的長期益處的了解不斷增加，消費者開始尋求支持整體健康和慢性病預防的產品。麩胺基硫是一種主要的抗氧化劑，有助於排毒並減少氧化壓力，使其成為促進預防的機能性食品和補充劑的重要成分。此外，這種趨勢在老齡化社會中尤其明顯，人們對促進長壽和健康老化的產品的需求不斷成長。

市場競爭激烈

麩胺基硫市場與多酚、Coenzyme Q10、維生素 C 和維生素 E 等其他知名抗氧化劑展開激烈競爭。隨著更新的抗氧化劑成分和化合物的推出，市場的競爭也可能變得更加激烈。此外，銷售麩胺基硫的公司必須不斷在行銷和教育上投入資金，以使其產品與競爭對手區分開來並保護更高的價格，這給他們的財務和資源帶來了壓力。

COVID-19 的影響：

COVID-19 大流行對麩胺基硫市場產生了重大影響，提高了消費者對免疫健康的認知，並增加了對富含抗氧化劑的產品的需求。此外，麩胺基硫具有減少氧化壓力和增強免疫力的潛力，使其在營養補充劑和機能性食品中越來越受歡迎。然而，疫情期間，生產和分銷受到物流困難、供應鏈中斷和原料短缺的阻礙。儘管存在這些障礙，但由於消費者優先考慮自己的健康，這場流行病開闢了新的市場，並增加了對麩胺基硫藥物和營養補充劑的需求。

還原型麩胺基硫(GSH) 產業預計將在預測期內成為最大的產業

預計麩胺基硫市場將由還原型麩胺基硫(GSH) 領域主導。其優越性的原因在於它被廣泛應用於化妝品、藥品、營養補充劑等各個領域。還原型麩胺基硫在免疫力增強補充劑和護膚配方中受到高度追捧，因為它具有強大的抗氧化品質、對抗氧化壓力的能力以及眾所周知的解毒過程參與作用。此外，其生物利​​用度和有效中和自由基的能力進一步鞏固了其作為製造商和消費者首選的地位，推動了需求並保持了主導市場佔有率。

在預測期內，靜脈注射（IV）麩胺基硫領域預計複合年成長率最高

在麩胺基硫市場中，靜脈注射 (IV)麩胺基硫細分市場預計將以最高的複合年成長率成長。靜脈注射療法的日益普及是這種快速成長的一個主要因素，它透過將營養物質直接輸送到血液中並快速吸收來確保最大的有效性。由於麩胺基硫在皮膚美白、抗衰老和排毒方面具有顯著的功效，診所和健康中心經常使用靜脈注射麩胺基硫。此外，醫療美容趨勢的上升和慢性病盛行率的上升正在增加對靜脈注射麩胺基硫治療的需求。

比例最高的地區：

由於亞太地區對藥品、化妝品和營養補充劑的需求量很大，預計該地區將佔據麩胺基硫市場的最大佔有率。對健康和保健、抗衰老療法和皮膚美白產品的日益關注，使得中國、日本和韓國等國家在生產和消費方面都處於領先地位。具有成本效益的生產方法和豐富的原料供應進一步強化了該地區的優勢。此外，該地區龐大的市場佔有率也是都市化、可支配收入增加以及消費者對麩胺基硫益處了解不斷增加的結果。

複合年成長率最高的地區：

北美地區的麩胺基硫市場預計將顯著成長，複合年成長率最高。消費者對保健品的興趣日益濃厚，特別是那些用於護膚、排毒和免疫系統支持的保健品，正在推動該地區對麩胺基硫的需求。市場成長是由完善的製藥和營養保健品行業以及對抗氧化劑益處的廣泛了解所推動的。此外，由於個人化營養和健康趨勢的上升以及可支配收入的增加，北美麩胺基硫市場預計也將繼續成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球麩胺基硫市場：依產品類型

  • 還原型麩胺基硫(GSH)
  • 氧化型麩胺基硫(GSSG)
  • 脂質體麩胺基硫
  • N-乙醯半胱胺酸（NAC）
  • S-麩胺基硫

第6章全球麩胺基硫市場：依形式

  • 口服膠囊或錠劑
  • 菱形
  • 液體
  • 靜脈注射 (IV)麩胺基硫
  • 外用霜
  • 吸入

第7章全球麩胺基硫市場：依來源分類

  • 自然資源
    • 植物來源
    • 動物起源
  • 合成來源

第8章全球麩胺基硫市場：依應用分類

  • 營養補充品/營養補充品
  • 護膚
  • 呼吸系統健康
  • 靜脈 (IV) 治療
  • 運動營養
  • 慢性病管理
  • 化妝品
  • 食品/飲料
  • 藥品
  • 其他用途

第9章全球麩胺基硫市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 公司概況

  • Atrium Innovations
  • Kohjin Life Sciences Co., Ltd.
  • Bachem Inc
  • Mitsubishi Corporation Life Science Limited
  • Ajinomoto Group
  • Now Health Group, Inc
  • Meteoric Biopharmaceuticals
  • Kyowa Hakko Bio Co., Ltd.
  • Shenzhen GSH Bio-Technology Co., Ltd.
  • Parchem Fine & Specialty Chemicals
  • Jarrow Formulas, Inc.
  • Cayman Chemical Company
  • Shandong Jincheng Bio-pharmaceutical Co., Ltd.
  • Kyungdong Pharmaceutical Co., Ltd
  • Anhui GSH Bio-Technology
Product Code: SMRC28305

According to Stratistics MRC, the Global Glutathione Market is accounted for $402.93 million in 2024 and is expected to reach $721.64 million by 2030 growing at a CAGR of 10.2% during the forecast period. Glutathione is a powerful antioxidant naturally found in cells, composed of three amino acids which are glutamine, cysteine, and glycine. By scavenging free radicals and reactive oxygen species, which can harm cells and play a part in aging and chronic illnesses, it plays a vital part in shielding the body from oxidative stress. Glutathione is also necessary for a number of metabolic functions, such as immune system function, protein repair, and DNA synthesis. By attaching itself to toxins in the liver for elimination, it also helps detoxify dangerous substances. Moreover, glutathione is used extensively in supplements and skincare products because of its many health benefits, especially its ability to improve skin health and encourage a balanced complexion.

According to the European Journal of Medical and Health Sciences, glutathione (GSH) is the most abundant free radical scavenger synthesized endogenously in humans, and its deficiency can lead to adverse health consequences. Studies have shown that glutathione levels can decrease by up to 50% in individuals with chronic diseases.

Market Dynamics:

Driver:

Increasing knowledge of health advantages

One of the main factors propelling market expansion is growing awareness of glutathione's health advantages. Glutathione is a potent antioxidant that aids in the reduction of oxidative stress and the neutralization of free radicals, both of which are connected to aging and chronic illnesses like diabetes, cancer, and cardiovascular disorders. It is a well-liked option for consumers who are concerned about their health because of its ability to strengthen the immune system and improve cellular health in general. Additionally, the demand for glutathione supplements has increased as a result of this increased awareness, especially among people looking to enhance their general health and avoid chronic diseases.

Restraint:

Expensive production and product costs

The high cost of production is one of the main factors limiting the glutathione market. It takes sophisticated technologies and a large investment in research and development to synthesize glutathione, especially in its reduced and bioavailable forms. This results in increased production costs that are transferred to customers, making glutathione products and supplements more costly than other antioxidants. Furthermore, the high cost frequently prevents a certain group of wealthy or health-conscious consumers from purchasing it, which limits market expansion in areas where consumers are price sensitive, especially in developing nations.

Opportunity:

Growing need for healthcare preventative solutions

There are plenty of prospects for the glutathione market due to the increased emphasis on preventative healthcare. Growing knowledge of the long-term advantages of preserving immunological and cellular health has led consumers to look for products that support general wellness and the prevention of chronic illnesses. Since glutathione is a master antioxidant that helps with detoxification and lowers oxidative stress, it is a crucial component of functional foods and supplements meant to promote prevention. Moreover, this trend is especially noticeable in aging populations, where there is a greater need for goods that promote longevity and healthy aging.

Threat:

Vigorous competition in the market

The market for glutathione is fiercely competitive with other well-known antioxidants like polyphenols, coenzyme Q10, and vitamins C and E. The development of glutathione-based products is seriously threatened by these substitutes, which are frequently more widely known and less expensive. The market's introduction of more recent antioxidant ingredients and compounds could also make competition even fiercer. Furthermore, businesses that sell glutathione must constantly spend money on marketing and education to set their products apart from the competition and defend their higher prices, which can put a strain on finances and resources.

Covid-19 Impact:

The COVID-19 pandemic had a major impact on the glutathione market by raising consumer awareness of immune health and resulting in a greater demand for products high in antioxidants. Moreover, glutathione has become increasingly popular in dietary supplements and functional foods due to its potential to lower oxidative stress and boost immunity. But during the pandemic, production and distribution were hampered by logistical difficulties, supply chain interruptions, and shortages of raw materials. Notwithstanding these obstacles, the pandemic opened up new markets as consumers placed a higher priority on their health, which increased demand for glutathione-based pharmaceutical and nutraceutical products.

The Reduced Glutathione (GSH) segment is expected to be the largest during the forecast period

The glutathione market is expected to be dominated by the reduced glutathione (GSH) segment. Its extensive use in a variety of sectors, such as cosmetics, pharmaceuticals, and nutraceutical, is what accounts for its dominance. Reduced glutathione is highly sought after for immune-boosting supplements and skincare formulations because of its well-known strong antioxidant qualities, capacity to fight oxidative stress, and involvement in detoxification processes. Additionally, its bioavailability and ability to effectively neutralize free radicals have further cemented its status as a manufacturer's and consumer's preferred option, boosting demand and preserving its dominant market share.

The Intravenous (IV) Glutathione segment is expected to have the highest CAGR during the forecast period

In the glutathione market, the intravenous (IV) glutathione segment is anticipated to grow at the highest CAGR. The growing popularity of IV therapies, which ensure maximum efficacy through direct nutrient delivery into the bloodstream and rapid absorption, is the primary driver of this rapid growth. Due to its alleged advantages in skin lightening, anti-aging, and detoxification, IV glutathione is frequently utilized in clinics and wellness centers. Furthermore, the growing trend of medical aesthetics and the rising incidence of chronic diseases have increased demand for IV glutathione treatments.

Region with largest share:

Due to the high demand for pharmaceuticals, cosmetics, and nutraceutical in the Asia Pacific region, the region is expected to hold the largest share of the glutathione market. A growing emphasis on health and wellness, anti-aging remedies, and skin-whitening products has made countries like China, Japan, and South Korea leaders in both production and consumption. Its dominance is further enhanced by the region's cost-effective manufacturing methods and plentiful supply of raw materials. Moreover, the region's sizable market share is also a result of urbanization, growing disposable incomes, and growing consumer knowledge of glutathione's advantages.

Region with highest CAGR:

The glutathione market is expected to grow significantly in the North American region, with the highest CAGR. In this area, the growing interest of consumers in health supplements, especially those for skin care, detoxification, and immune system support, is driving the demand for glutathione. Market growth is facilitated by the existence of a firmly established pharmaceutical and nutraceutical sector as well as widespread knowledge of the advantages of antioxidants. Additionally, the glutathione market in North America is also anticipated to continue growing as a result of the growing trend of personalized nutrition and wellness as well as rising disposable incomes.

Key players in the market

Some of the key players in Glutathione market include Atrium Innovations, Kohjin Life Sciences Co., Ltd., Bachem Inc, Mitsubishi Corporation Life Science Limited, Ajinomoto Group, Now Health Group, Inc, Meteoric Biopharmaceuticals, Kyowa Hakko Bio Co., Ltd., Shenzhen GSH Bio-Technology Co., Ltd., Parchem Fine & Specialty Chemicals, Jarrow Formulas, Inc., Cayman Chemical Company, Shandong Jincheng Bio-pharmaceutical Co., Ltd., Kyungdong Pharmaceutical Co., Ltd and Anhui GSH Bio-Technology.

Key Developments:

In April 2024, Kyowa Hakko Bio, Co., Ltd. and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings Co., has opened its expanded citicoline manufacturing facility at its Kyowa Hakko Bio Yamaguchi Production Center in Hofu City, Yamaguchi Prefecture, Japan. With the expanded facility, the Kirin Group is planning to integrate citicoline into upcoming product development initiatives.

In November 2023, Ajinomoto Co., Inc. and Forge Biologics announced that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million1. This acquisition in the current biotech market is a remarkable testament to the technical advancements, world-class facility, and experienced capable leadership at Forge.

In March 2023, Bachem Group announced that it has signed a new framework agreement to provide large volumes of peptides following a joint development project. Manufacturing is to primarily occur at Bachem's new large-scale production facility currently under construction in Bubendorf.

Product Types Covered:

  • Reduced Glutathione (GSH)
  • Oxidized Glutathione (GSSG)
  • Liposomal Glutathione
  • N-acetylcysteine (NAC)
  • S-Acetyl Glutathione

Forms Covered:

  • Oral Capsules or Tablets
  • Lozenges
  • Liquids
  • Intravenous (IV) Glutathione
  • Topical Creams
  • Inhalation

Sources Covered:

  • Natural Sources
  • Synthetic Sources

Applications Covered:

  • Nutritional Supplements/ Nutraceutical Supplements
  • Skin Care
  • Respiratory Health
  • Intravenous (IV) Therapy
  • Sports Nutrition
  • Chronic Illness Management
  • Cosmetics
  • Food & Beverage
  • Pharmaceuticals
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Glutathione Market, By Product Type

  • 5.1 Introduction
  • 5.2 Reduced Glutathione (GSH)
  • 5.3 Oxidized Glutathione (GSSG)
  • 5.4 Liposomal Glutathione
  • 5.5 N-acetylcysteine (NAC)
  • 5.6 S-Acetyl Glutathione

6 Global Glutathione Market, By Form

  • 6.1 Introduction
  • 6.2 Oral Capsules or Tablets
  • 6.3 Lozenges
  • 6.4 Liquids
  • 6.5 Intravenous (IV) Glutathione
  • 6.6 Topical Creams
  • 6.7 Inhalation

7 Global Glutathione Market, By Source

  • 7.1 Introduction
  • 7.2 Natural Sources
    • 7.2.1 Plant-based
    • 7.2.2 Animal-based
  • 7.3 Synthetic Sources

8 Global Glutathione Market, By Application

  • 8.1 Introduction
  • 8.2 Nutritional Supplements/ Nutraceutical Supplements
  • 8.3 Skin Care
  • 8.4 Respiratory Health
  • 8.5 Intravenous (IV) Therapy
  • 8.6 Sports Nutrition
  • 8.7 Chronic Illness Management
  • 8.8 Cosmetics
  • 8.9 Food & Beverage
  • 8.10 Pharmaceuticals
  • 8.11 Other Applications

9 Global Glutathione Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Atrium Innovations
  • 11.2 Kohjin Life Sciences Co., Ltd.
  • 11.3 Bachem Inc
  • 11.4 Mitsubishi Corporation Life Science Limited
  • 11.5 Ajinomoto Group
  • 11.6 Now Health Group, Inc
  • 11.7 Meteoric Biopharmaceuticals
  • 11.8 Kyowa Hakko Bio Co., Ltd.
  • 11.9 Shenzhen GSH Bio-Technology Co., Ltd.
  • 11.10 Parchem Fine & Specialty Chemicals
  • 11.11 Jarrow Formulas, Inc.
  • 11.12 Cayman Chemical Company
  • 11.13 Shandong Jincheng Bio-pharmaceutical Co., Ltd.
  • 11.14 Kyungdong Pharmaceutical Co., Ltd
  • 11.15 Anhui GSH Bio-Technology

List of Tables

  • Table 1 Global Glutathione Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Glutathione Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Glutathione Market Outlook, By Reduced Glutathione (GSH) (2022-2030) ($MN)
  • Table 4 Global Glutathione Market Outlook, By Oxidized Glutathione (GSSG) (2022-2030) ($MN)
  • Table 5 Global Glutathione Market Outlook, By Liposomal Glutathione (2022-2030) ($MN)
  • Table 6 Global Glutathione Market Outlook, By N-acetylcysteine (NAC) (2022-2030) ($MN)
  • Table 7 Global Glutathione Market Outlook, By S-Acetyl Glutathione (2022-2030) ($MN)
  • Table 8 Global Glutathione Market Outlook, By Form (2022-2030) ($MN)
  • Table 9 Global Glutathione Market Outlook, By Oral Capsules or Tablets (2022-2030) ($MN)
  • Table 10 Global Glutathione Market Outlook, By Lozenges (2022-2030) ($MN)
  • Table 11 Global Glutathione Market Outlook, By Liquids (2022-2030) ($MN)
  • Table 12 Global Glutathione Market Outlook, By Intravenous (IV) Glutathione (2022-2030) ($MN)
  • Table 13 Global Glutathione Market Outlook, By Topical Creams (2022-2030) ($MN)
  • Table 14 Global Glutathione Market Outlook, By Inhalation (2022-2030) ($MN)
  • Table 15 Global Glutathione Market Outlook, By Source (2022-2030) ($MN)
  • Table 16 Global Glutathione Market Outlook, By Natural Sources (2022-2030) ($MN)
  • Table 17 Global Glutathione Market Outlook, By Plant-based (2022-2030) ($MN)
  • Table 18 Global Glutathione Market Outlook, By Animal-based (2022-2030) ($MN)
  • Table 19 Global Glutathione Market Outlook, By Synthetic Sources (2022-2030) ($MN)
  • Table 20 Global Glutathione Market Outlook, By Application (2022-2030) ($MN)
  • Table 21 Global Glutathione Market Outlook, By Nutritional Supplements/ Nutraceutical Supplements (2022-2030) ($MN)
  • Table 22 Global Glutathione Market Outlook, By Skin Care (2022-2030) ($MN)
  • Table 23 Global Glutathione Market Outlook, By Respiratory Health (2022-2030) ($MN)
  • Table 24 Global Glutathione Market Outlook, By Intravenous (IV) Therapy (2022-2030) ($MN)
  • Table 25 Global Glutathione Market Outlook, By Sports Nutrition (2022-2030) ($MN)
  • Table 26 Global Glutathione Market Outlook, By Chronic Illness Management (2022-2030) ($MN)
  • Table 27 Global Glutathione Market Outlook, By Cosmetics (2022-2030) ($MN)
  • Table 28 Global Glutathione Market Outlook, By Food & Beverage (2022-2030) ($MN)
  • Table 29 Global Glutathione Market Outlook, By Pharmaceuticals (2022-2030) ($MN)
  • Table 30 Global Glutathione Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.